Female Cancer Patients' Preference For Sexual Health Interventions

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01084642
First received: March 9, 2010
Last updated: July 24, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to survey female cancer patients' awareness of and preference for methods to improve sexual health. This information will help to improve our understanding of the needs and preferences for sexual health strategies and interventions of our female patients.

The findings of this survey will also be used to develop feasible sexual health resources for our patients and enhance the success of grant proposals to support future sexual health interventions at MSKCC.


Condition
Breast Cancer
Gynecologic Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Pilot Study Surveying Female Cancer Patients' Preference For Sexual Health Interventions

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • Participant' awareness of sexual health issues & preference for sexual health intervention [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To assess & describe female cancer patients' attitudes towards & preference of methods to receive sexual health information (verbal or written) & psychosexual education patient information cards or intervention modality (telephone, in-person or online). [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: March 2010
Estimated Study Completion Date: March 2015
Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
survey
Participants will be asked to complete a survey as a one time assessment.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Clinics at MSKCC

Criteria

Inclusion Criteria:

  • Participants must be able to communicate in English to complete the tests.
  • Study group of breast and/or gynecological cancer survivors.
  • History of Primary diagnosis of breast and/or gynecological cancer
  • At least 21 years of age.
  • In the judgement of the consenting professional able to provide informed consent
  • In the judgement of the consenting professional, able to communicate well enough in English through verbal and written communication to complete the study assessments.

Exclusion Criteria:

  • In the judgement of the consenting professional, the individual is able to provide informed consent.
  • Patients with a psychiatric disorder precluding response to the surveys.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01084642

Locations
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Investigators
Principal Investigator: Jeanne Carter, PhD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01084642     History of Changes
Other Study ID Numbers: 10-034
Study First Received: March 9, 2010
Last Updated: July 24, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Survey
Sexual Health Issues
10-034

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 26, 2014